0.30 USD
▲+0.00+22.45%
盘后 0.25 +2.04%
2026-08-03
市值
$12.31M
市盈率
—
EPS
-1.83
股息率
—
52 周区间
0.20 – 5.14
成交量
117.92M
Beta
0.39
目标价
1.00
52W 低 0.2052W 高 5.14
价格走势
公司简介
Vistagen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of therapies for neuropsychiatric and neurological disorders. The company’s product pipeline includes Fasedienol, an investigational pherine nasal spray that is in Phase III clinical trial for the treatment of anxiety in adults with social anxiety disorder; and Itruvone, an odorless synthetic investigational neuroactive pherine nasal spray, which is in Phase IIa clinical trial to treat major depressive disorder. It also deve...